These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17493313)

  • 21. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.
    Moreno SG; Novielli N; Cooper NJ
    J Heart Lung Transplant; 2012 May; 31(5):450-8. PubMed ID: 22115674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
    Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
    Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced external counterpulsation for the treatment of stable angina and heart failure: a systematic review and economic analysis.
    McKenna C; McDaid C; Suekarran S; Hawkins N; Claxton K; Light K; Chester M; Cleland J; Woolacott N; Sculpher M
    Health Technol Assess; 2009 Apr; 13(24):iii-iv, ix-xi, 1-90. PubMed ID: 19409154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and effectiveness of different methods of earwax removal: a systematic review and economic evaluation.
    Clegg AJ; Loveman E; Gospodarevskaya E; Harris P; Bird A; Bryant J; Scott DA; Davidson P; Little P; Coppin R
    Health Technol Assess; 2010 Jun; 14(28):1-192. PubMed ID: 20546687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support.
    Nunes AJ; MacArthur RG; Kim D; Singh G; Buchholz H; Chatterley P; Klarenbach SW
    Value Health; 2016 Jun; 19(4):494-504. PubMed ID: 27325342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK.
    Borisenko O; Wylie G; Payne J; Bjessmo S; Smith J; Firmin R; Yonan N
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):41-8. PubMed ID: 24667583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.
    Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A
    Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device.
    Silvestry SC; Mahr C; Slaughter MS; Levy WC; Cheng RK; May DM; Ismyrloglou E; Tsintzos SI; Tuttle E; Cook K; Birk E; Gomes A; Graham S; Cotts WG
    ASAIO J; 2020 Aug; 66(8):862-870. PubMed ID: 32740129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To explore the prevalence and outcomes of advance care planning for patients with left ventricular assist devices: A review.
    Delmaczynska E; Newham R
    J Clin Nurs; 2019 May; 28(9-10):1365-1379. PubMed ID: 30552798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Destination therapy: does progress depend on left ventricular assist device development?
    von Bayern MP; Cadeiras M; Deng MC
    Heart Fail Clin; 2007 Jul; 3(3):349-67. PubMed ID: 17723941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure.
    Griffin EA; Wonderling D; Ludman AJ; Al-Mohammad A; Cowie MR; Hardman SMC; McMurray JJV; Kendall J; Mitchell P; Shote A; Dworzynski K; Mant J
    Value Health; 2017 Sep; 20(8):1025-1033. PubMed ID: 28964433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.
    Alba AC; Alba LF; Delgado DH; Rao V; Ross HJ; Goeree R
    Circulation; 2013 Jun; 127(24):2424-35. PubMed ID: 23697907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Systematic Review of Cost-Effectiveness Analyses of Left Ventricular Assist Devices: Issues and Challenges.
    Schmier JK; Patel JD; Leonhard MJ; Midha PA
    Appl Health Econ Health Policy; 2019 Feb; 17(1):35-46. PubMed ID: 30345458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventricular assist devices: destination therapy or just another stop on the road?
    Mehra MR
    Curr Heart Fail Rep; 2004; 1(1):36-40. PubMed ID: 16036023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter by moreno regarding article, "cost-effectiveness analysis of continuous flow left ventricular assist devices as destination therapy".
    Moreno SG
    Circ Heart Fail; 2012 Mar; 5(2):e50. PubMed ID: 22438529
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of economic evaluations of ventricular assist devices: A systematic review.
    Fontenay S; Catarino L; Snoussi S; van den Brink H; Pineau J; Prognon P; Martelli N
    Int J Technol Assess Health Care; 2020 Jun; ():1-8. PubMed ID: 32618521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy.
    Entwistle JWC
    J Thorac Cardiovasc Surg; 2017 Oct; 154(4):1315-1318. PubMed ID: 28483265
    [No Abstract]   [Full Text] [Related]  

  • 40. Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?
    Hrobowski T; Lanfear DE
    Curr Heart Fail Rep; 2013 Mar; 10(1):101-7. PubMed ID: 23129352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.